Cargando…

Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases

BACKGROUND AND AIMS: Inflammatory bowel diseases are highly debilitating conditions that require constant monitoring and life-long medication. Current treatments are focused on systemic administration of immunomodulatory drugs, but they have a broad range of undesirable side-effects. RNA interferenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clément, Flora, Nougarède, Adrien, Combe, Stéphanie, Kermarrec, Frédérique, Dey, Arindam K, Obeid, Patricia, Millet, Arnaud, Navarro, Fabrice P, Marche, Patrice N, Sulpice, Eric, Gidrol, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864631/ https://www.ncbi.nlm.nih.gov/pubmed/34286840 http://dx.doi.org/10.1093/ecco-jcc/jjab129

Ejemplares similares

Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1
por: Hartwig, Olga, et al.
Publicado: (2022)

The miR-17 Family Links p63 Protein to MAPK Signaling to Promote the Onset of Human Keratinocyte Differentiation
por: Wu, Ning, et al.
Publicado: (2012)

Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery
por: Dey, Arindam K., et al.
Publicado: (2021)

Distinct outcomes of CRL–Nedd8 pathway inhibition reveal cancer cell plasticity
por: Rulina, Anastasia V, et al.
Publicado: (2016)

Comprehensive Analysis of Human Cells Motion under an Irrotational AC Electric Field in an Electro-Microfluidic Chip
por: Vaillier, Clarisse, et al.
Publicado: (2014)

A statistically inferred microRNA network identifies breast cancer target miR-940 as an actin cytoskeleton regulator
por: Bhajun, Ricky, et al.
Publicado: (2015)

Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin
por: Tang, Qi, et al.
Publicado: (2023)

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017)

Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles
por: Pan, Jingtong, et al.
Publicado: (2018)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19
por: Banerjee, Arindam, et al.
Publicado: (2021)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010)

Retrovirus-delivered siRNA
por: Devroe, Eric, et al.
Publicado: (2002)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

Genome-wide screens for effective siRNAs through assessing the size of siRNA effects
por: Zhang, Xiaohua Douglas
Publicado: (2008)

Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities
por: Ichihara, Masatoshi, et al.
Publicado: (2007)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA
por: Sun, Jiangbin, et al.
Publicado: (2012)

Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6
por: Healey, Gareth D., et al.
Publicado: (2014)

Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 siRNA
por: Zhang, Hongjia, et al.
Publicado: (2020)

sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database
por: Shah, Jyoti K, et al.
Publicado: (2007)

Expression data of HeLa cells treated with CENP-E siRNA or Eg5 siRNA in the presence of BubR1 siRNA
por: Nakayama, Yusuke, et al.
Publicado: (2015)

Φ-score: A cell-to-cell phenotypic scoring method for sensitive and selective hit discovery in cell-based assays
por: Guyon, Laurent, et al.
Publicado: (2015)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

siRNAdb: a database of siRNA sequences
por: Chalk, Alistair M., et al.
Publicado: (2005)

siRNAdb: a database of siRNA sequences
por: Chalk, Alistair M., et al.
Publicado: (2005)

Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012)

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
por: Foster, Donald J., et al.
Publicado: (2018)

Predicting siRNA efficacy based on multiple selective siRNA representations and their combination at score level
por: He, Fei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1ub54n2qtq2fnppo8vvg0bhbv1